These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 35955463)
1. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells. Messeha SS; Zarmouh NO; Antonie L; Soliman KFA Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955463 [TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells. Adinew GM; Messeha S; Taka E; Mochona B; Redda KK; Soliman KFA Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373025 [TBL] [Abstract][Full Text] [Related]
3. Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells. Messeha SS; Noel S; Zarmouh NO; Womble T; Latinwo LM; Soliman KFA Cancer Genomics Proteomics; 2023; 20(4):323-342. PubMed ID: 37400144 [TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells. Messeha SS; Zarmouh NO; Mendonca P; Alwagdani H; Kolta MG; Soliman KFA PLoS One; 2018; 13(7):e0201116. PubMed ID: 30059519 [TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells. Mendonca P; Horton A; Bauer D; Messeha S; Soliman KFA PLoS One; 2019; 14(10):e0215269. PubMed ID: 31665136 [TBL] [Abstract][Full Text] [Related]
6. Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Kanga KJW; Mendonca P; Soliman KFA; Ferguson DT; Darling-Reed SF Anticancer Res; 2021 Dec; 41(12):5919-5933. PubMed ID: 34848446 [TBL] [Abstract][Full Text] [Related]
7. Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway. Kuang W; Gu Q; Zhou Y; Xiao X; He D; Deng Q Cell Biochem Biophys; 2023 Dec; 81(4):727-735. PubMed ID: 37658975 [TBL] [Abstract][Full Text] [Related]
8. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089 [TBL] [Abstract][Full Text] [Related]
10. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages. Nordin FJ; Pearanpan L; Chan KM; Kumolosasi E; Yong YK; Shaari K; Rajab NF PLoS One; 2021; 16(8):e0256012. PubMed ID: 34379689 [TBL] [Abstract][Full Text] [Related]
12. A specific RAGE-binding peptide inhibits triple negative breast cancer growth through blocking of Erk1/2/NF-κB pathway. Dai X; Hou Y; Deng T; Lin G; Cao Y; Yu G; Wei W; Zheng Q; Huang L; Ma S Eur J Pharmacol; 2023 Sep; 954():175861. PubMed ID: 37380046 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells. Jin Y; Huynh DTN; Myung CS; Heo KS Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638797 [TBL] [Abstract][Full Text] [Related]
14. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
15. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling. Shin WS; Oh SW; Park HN; Kim JH; Lee ST Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569547 [TBL] [Abstract][Full Text] [Related]
17. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling. Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386 [TBL] [Abstract][Full Text] [Related]
18. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
20. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]